Physician profile
Ladly Abraham
NPI 1972537090
$370,708.91
in general payments reported to CMS, 2019-2025
45 companies · $69K in 2025
The $69K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $12K · 2021: $16K · 2022: $14K · 2023: $88K · 2024: $115K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $199K · Travel and Lodging: $34K · Food and Beverage: $18K · Consulting Fee: $13K · Honoraria: $8,000 · Education: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $198,625.00 |
| Travel and Lodging | $34,496.67 |
| Food and Beverage | $17,517.17 |
| Consulting Fee | $13,314.00 |
| Honoraria | $8,000.00 |
| Education | $280.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $184,624.37 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $113,469.19 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Sunovion Pharmaceuticals INC. | $19,194.17 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18,897.44 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Verona Pharma, INC. | $9,157.37 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $6,467.13 | 2021-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $4,798.72 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $1,794.29 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Noah Medical Corporation | $1,702.42 | 2023-2024 | Galaxy |
| Grifols USA, LLC | $1,147.95 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $1,048.39 | 2020-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $945.42 | 2021-2025 | Dupixent |
| Genzyme Corporation | $897.38 | 2020-2025 | |
| Hill-Rom Company, INC | $875.00 | 2021 | |
| Electromed, INC. | $715.20 | 2021-2025 | Smartvest |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $600.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $543.45 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $513.38 | 2019-2024 | |
| Genentech USA, INC. | $367.70 | 2019-2023 | Xolair |
| Baxter Healthcare | $303.40 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Amgen INC. | $285.85 | 2022-2025 | Tezspire, Tavneos |
| Janssen Pharmaceuticals, INC | $281.94 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $235.16 | 2023-2025 | Glassia |
| Mallinckrodt Enterprises LLC | $225.71 | 2019 | |
| Merck Sharp & Dohme LLC | $214.43 | 2019-2025 | Winrevair, Zerbaxa, Belsomra |
| Intuitive Surgical, INC. | $201.68 | 2024 | |
| Viatris Specialty LLC | $190.13 | 2025 | Yupelri |
| Philips North America LLC | $177.04 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Insmed, INC. | $160.55 | 2022-2025 | Arikayce, Brinsupri |
| Sanofi-Aventis U.S. LLC | $124.98 | 2023-2025 | |
| Advanced Respiratory, INC | $122.73 | 2019-2021 | |
| Vifor Pharma, INC. | $89.93 | 2024-2025 | Zemaira |
| Inogen, INC. | $51.33 | 2022-2023 | Inogen At Home Stationary Concentrator |
| Pfizer INC. | $49.92 | 2019-2024 | |
| Circassia INC. | $41.11 | 2019 | |
| Optinose US, INC. | $35.93 | 2021 | |
| Veran Medical Technologies, INC. | $21.90 | 2020 | |
| Hikma Pharmaceuticals USA | $20.31 | 2024 | Ryaltris |
| Resmed Corp | $19.94 | 2024 | |
| Ani Pharmaceuticals, INC. | $19.09 | 2025 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $18.42 | 2019 | |
| Gilead Sciences, INC. | $17.32 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.63 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.67 | 2021 | |
| Itamar Medical INC | $9.84 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ladly Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.